Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator-Preliminary report

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 146, Issue 2, 2009, Pages 165-168

  Karina, Engel ^a   Tomasz, Płonka ^a   Bilar, Marek ^a   Agnieszka, Orzińska ^b   Ewa, Brojer ^b   Elzbieta, Ronin Walkowska ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Female fetuses; Fetal DNA; Preeclampsia

Indexed keywords

DNA; FETAL DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; ECHOGRAPHY; FEMALE; FETAL RESEARCH; FETUS; HUMAN; MATERNAL BLOOD; MOTHER FETUS RELATIONSHIP; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 70349510116     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.06.016     Document Type: Article

References (24)

1. Krabchi N.C., Gadji M., Samassekou O., Gregoire M.C., Forest J.C., and Drouin R. Quantification of fetal nucleated cells in maternal blood of pregnant women with a male trisomy 21 fetus using molecular cytogenetic techniques. Prenat Diagn 26 (2006) 145-150
2. Lo Y.M., Tein M.S.C., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62 (1998) 768-775
3. Chen C.-P., Chern S.-R., and Wang W. Fetal DNA analyzed in plasma from a mothers three consecutive pregnancies to detect paternally inherited aneuploidy. Clin Chem 47 (2001) 937-939
4. Lo Y.M., Lau T.K., Chan L.Y., Leung T.N., and Chang A.M. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46 (2000) 1301-1309
5. Shimada K., Murakami K., Shozu M., Segawa T., Sumtani H., and Inoue M. Sex determining region Y levels in maternal plasma: evaluation in abnormal pregnancy. J Obstet Gynecol Res 30 (2004) 148-154
6. Lo Y.M.D., Zhang J., Leung T.N., Lau T.K., Chang A.M., and Hjelm N.M. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64 (1999) 232-234
7. Hahn S., and Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into preeclmpsia. Hum Reprod Update 8 (2002) 501-508
8. Hahn S., Huppertz B., and Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation?. Placenta 26 (2005) 515-526
9. Wong B.C., and Lo Y.M. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev Mol Diagn 3 (2003) 785-797
10. Costa J.M., Giovangrandi Y., Ernault P., et al. Fetal RhD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 119 (2002) 255-260
11. Hromadnicova I., Vechetova L., Vesela K., et al. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 20 (2005) 275-280
12. Legler T., Lynen R., Maas J., et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apheresis Sci 27 (2002) 217-223
13. Chiu R.W., Lau T.K., Cheung P.T., Gong Z.Q., Leung T.N., and Lo Y.M. Noninvasise prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 48 (2002) 778-780
14. Li Y., Holzgreve W., Page-Chrisianens G.C., Gille J.J., and Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn 24 (2004) 896-898
15. Bischoff F.Z., Sinacori M.K., Dang D.D., et al. Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implication for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update 8 (2002) 493-500
16. Levine R.J., Qian C., Leshane E.S., et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 190 (2004) 707-713
17. Engel K., Plonka T., Bilar M., Orzinska A., Brojer E., and Ronin-Walknowska E. The correlation between clinical characteristics of preeclampsia and the concentration of fetal DNA in maternal circulation. Eur J Obstet Gynecol 139 (2008) 256-260
18. Lo Y.M.D., Leung T.N., Tein M.S., et al. Quantitative abnormalities of fetal DNA in maternal serum in pre-eclampsia. Clin Chem 45 (1999) 184-188
19. Swinkels D.W., de Kok J.B., Hendriks J.C., Wigerinck E., Zusterzeel P.L.M., and Steegers E.A. Haemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal plasma and serum. Clin Chem 48 (2002) 650-653
20. Brojer E., Żupanska B., Guz K., Orzinska A., and Kalinska A. Noninvasive determination of fetal RhD status by examination of cell-free DNA in maternal plasma. Transfusion 45 (2005) 1473-1480
21. Alizadeh M., Bernard M., Danic B., et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real time quantitative polymerase chain reaction. Blood 99 (2002) 4618-4625
22. Smid M., Vassalo A., Lagona F., et al. Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann NY Acad Sci 945 (2001) 132-137
23. Zhong X.Y., Burk M.R., Troeger C., et al. Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 96 (2000) 991-996
24. Zhong X.Y., Laivuori H., Livingston J.C., et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic amid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184 (2001) 414-419